Eversept Partners’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-16,200
Closed -$6.79M – 120
2025
Q3
$6.79M Buy
+16,200
New +$5.45M 0.47% 46

Other funds holding UTHR

Eversept Partners's UTHR Position: Q3 2026 in Review

Eversept Partners increased its United Therapeutics (UTHR) stake by 13% in Q3 2026, buying an estimated $19.2M and bringing the position to 324,729 shares worth $176M. The position accounts for 9.46% of the portfolio, ranked #1.

Eversept Partners first reported a position in UTHR in Q2 2020 and has held it in 26 quarters since. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Eversept Partners held 324,729 shares of United Therapeutics worth $176M as of Q3 2026.
  • Eversept Partners bought 37,061 United Therapeutics shares in Q3 2026, an estimated $19.2M.
  • United Therapeutics made up 9.46% of Eversept Partners's portfolio in Q3 2026, its #1 holding.
  • Eversept Partners first reported a position in United Therapeutics in Q2 2020 and has held it in 26 quarters since.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.